| A randomized trial of bevacizumab for newly diagnosed glioblastoma MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ... New England Journal of Medicine 370 (8), 699-708, 2014 | 2943 | 2014 |
| Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402 G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ... Journal of clinical oncology 31 (3), 337, 2013 | 1232 | 2013 |
| Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma JC Buckner, EG Shaw, SL Pugh, A Chakravarti, MR Gilbert, GR Barger, ... New England Journal of Medicine 374 (14), 1344-1355, 2016 | 993 | 2016 |
| Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group … G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ... J Clin Oncol 24 (18), 2707-2714, 2006 | 858 | 2006 |
| Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with … L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ... International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004 | 667 | 2004 |
| Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH JG Cairncross, M Wang, RB Jenkins, EG Shaw, C Giannini, DG Brachman, ... Journal of clinical oncology 32 (8), 783, 2014 | 456 | 2014 |
| Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802 EG Shaw, M Wang, SW Coons, DG Brachman, JC Buckner, KJ Stelzer, ... Journal of Clinical Oncology 30 (25), 3065, 2012 | 372 | 2012 |
| Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 … MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ... The Lancet 390 (10103), 1645-1653, 2017 | 364 | 2017 |
| Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial EG Shaw, B Berkey, SW Coons, D Bullard, D Brachman, JC Buckner, ... Journal of neurosurgery 109 (5), 835-841, 2008 | 335 | 2008 |
| p53 Mutation Does Not Correlate with Radiosensitivity in 24 Head and Neck Cancer Cell Lines DG Brachman, M Beckett, D Graves, D Haraf, E Vokes, RR Weichselbaum Cancer research 53 (16), 3667-3669, 1993 | 305 | 1993 |
| Occurrence of p53 Gene Deletions and Human Papilloma Virus Infection in Human Head and Neck Cancer DG Brachman, D Graves, E Vokes, M Beckett, D Haraf, A Montag, ... Cancer Research 52 (17), 4832-4836, 1992 | 299 | 1992 |
| An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity ME Oppenlander, AB Wolf, LA Snyder, R Bina, JR Wilson, SW Coons, ... Journal of neurosurgery 120 (4), 846-853, 2014 | 277 | 2014 |
| Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539 L Rogers, P Zhang, MA Vogelbaum, A Perry, LS Ashby, JM Modi, ... Journal of neurosurgery 129 (1), 35-47, 2017 | 231 | 2017 |
| Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. DJ Haraf, E Nodzenski, D Brachman, R Mick, A Montag, D Graves, ... Clinical cancer research: an official journal of the American Association …, 1996 | 211 | 1996 |
| Phase 2 study of temozolomide-based chemoradiation therapy for high-risk low-grade gliomas: preliminary results of Radiation Therapy Oncology Group 0424 BJ Fisher, C Hu, DR Macdonald, GJ Lesser, SW Coons, DG Brachman, ... International Journal of Radiation Oncology* Biology* Physics 91 (3), 497-504, 2015 | 182 | 2015 |
| RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients A Chakravarti, M Wang, HI Robins, T Lautenschlaeger, WJ Curran, ... International Journal of Radiation Oncology* Biology* Physics 85 (5), 1206-1211, 2013 | 163 | 2013 |
| Failure-free survival following brachytherapy alone or external beam irradiation alone for T1–2 prostate tumors in 2222 patients: results from a single practice DG Brachman, T Thomas, J Hilbe, DC Beyer International Journal of Radiation Oncology* Biology* Physics 48 (1), 111-117, 2000 | 157 | 2000 |
| The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection DA Hardesty, AB Wolf, DG Brachman, HL McBride, E Youssef, P Nakaji, ... Journal of neurosurgery 119 (2), 475-481, 2013 | 155 | 2013 |
| RTOG 0825: Phase III double-blind placebo-controlled trial evaluating bevacizumab (Bev) in patients (Pts) with newly diagnosed glioblastoma (GBM). MR Gilbert, J Dignam, M Won, DT Blumenthal, MA Vogelbaum, ... Journal of Clinical Oncology 31 (18_suppl), 1-1, 2013 | 144 | 2013 |
| Net clinical benefit analysis of radiation therapy oncology group 0525: a phase III trial comparing conventional adjuvant temozolomide with dose-intensive temozolomide in … TS Armstrong, JS Wefel, M Wang, MR Gilbert, M Won, A Bottomley, ... Journal of Clinical Oncology 31 (32), 4076, 2013 | 141 | 2013 |
